Health Care • Industrial Specialties
$6.63 ▲ +0.13
(+2.00%)
MKT CAP: $50.3M • VOL: 48.4K
52W L $4 52W H $10
ROARABLE / RQD
D- • 35/100
PIOTROSKI
2 / 9
COCH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $241.0K | $225.0K | $316.0K |
| YoY Revenue Growth % | +7.1% | -28.8% | — |
| Gross Profit | -$633.0K | -$517.0K | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$22.3M | -$19.3M | -$18.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$23.8M | -$20.8M | -$29.9M |
| EBITDA (Normalized) | -$22.1M | -$18.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.2M | -$17.9M | -$17.1M |
| Capital Expenditures (CapEx) | $179.0K | $980.0K | — |
| Free Cash Flow (FCF) | -$18.4M | -$18.9M | -$17.1M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$12.2M | -$18.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR COCH.